{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T03:04:50Z","timestamp":1770519890983,"version":"3.49.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA018832"],"award-info":[{"award-number":["R01 DA018832"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R03 DA016415"],"award-info":[{"award-number":["R03 DA016415"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.ejphar.2007.05.007","type":"journal-article","created":{"date-parts":[[2007,5,15]],"date-time":"2007-05-15T09:30:32Z","timestamp":1179221432000},"page":"84-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":125,"title":["Reinstatement of cocaine place-conditioning prevented by the peptide kappa-opioid receptor antagonist arodyn"],"prefix":"10.1016","volume":"569","author":[{"given":"A.N.","family":"Carey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Borozny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.V.","family":"Aldrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.P.","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2007.05.007_bib35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0149-7634(94)00021-R","article-title":"Conditioned place preference using opiate and stimulant drugs: a meta-analysis","volume":"19","author":"Bardo","year":"1995","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2007.05.007_bib1","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s00213-005-0167-4","article-title":"Differential effects of the novel kappa-opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats","volume":"183","author":"Beardsley","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2007.05.007_bib2","doi-asserted-by":"crossref","first-page":"5617","DOI":"10.1021\/jm025575g","article-title":"Identification of arodyn, a novel acetylated dynorphin A-(1-11) analogue, as a \u03ba opioid receptor antagonist","volume":"45","author":"Bennett","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2007.05.007_bib3","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1399-3011.2005.00216.x","article-title":"Structure\u2013activity relationships of arodyn, a novel acetylated kappa-opioid receptor antagonist","volume":"65","author":"Bennett","year":"2005","journal-title":"J. Pept. Res."},{"key":"10.1016\/j.ejphar.2007.05.007_bib4","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0022-3565(25)12847-4","article-title":"Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice","volume":"277","author":"Bilsky","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.05.007_bib5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00213-004-2138-6","article-title":"Influence of the dose and the number of drug-context pairings on the magnitude and the long-lasting retention of cocaine-induced conditioned place preference in C57Bl\/6J mice","volume":"180","author":"Brabant","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2007.05.007_bib6","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1208\/aapsj060436","article-title":"Stabilized dynorphin derivatives for modulating antinociceptive activity in morphine tolerant rats: effect of different routes of administration","volume":"6","author":"Brugos","year":"2004","journal-title":"AAPS J."},{"key":"10.1016\/j.ejphar.2007.05.007_bib7","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s002130050935","article-title":"Systematic effects of E-2078, a stabilized dynorphin A(1-8) analog, in rhesus monkeys","volume":"143","author":"Butelman","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2007.05.007_bib8","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1021\/jm9706729","article-title":"Pharmacotherapies for treatment of cocaine abuse: preclinical aspects","volume":"42","author":"Carroll","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2007.05.007_bib9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejphar.2004.08.028","article-title":"Pharmacological properties of JDTic: a novel kappa-opioid receptor antagonist","volume":"501","author":"Carroll","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.05.007_bib10","first-page":"645","article-title":"Selectivity of Ligands for Opioid Receptors","volume":"vol. 104, pt. 1","author":"Corbett","year":"1993"},{"key":"10.1016\/j.ejphar.2007.05.007_bib11","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/0006-2952(75)90152-5","article-title":"Studies on the distinction between uptake inhibition and release of [3H]dopamine in rat brain tissue slices","volume":"24","author":"Heikkila","year":"1975","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.05.007_bib12","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1038\/sj.bjp.0703982","article-title":"Long-lasting antinociceptive effects of a novel dynorphin analogue, Tyr-D-Ala-Phe-Leu-Arg\u03a8(CH2NH)Arg-NH2, in mice","volume":"132","author":"Hiramatsu","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.05.007_bib13","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/S0022-3565(25)11434-1","article-title":"Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test","volume":"260","author":"Horan","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.05.007_bib36","article-title":"Monitoring the future. National results on adolescent drug use: overview of key findings, 2005","author":"Johnston","year":"2006","journal-title":"(NIH Publication No. 06-5882). National Institute on Drug Abuse, Bethesda, Maryland"},{"key":"10.1016\/j.ejphar.2007.05.007_bib14","series-title":"Psychopharmacology: The Third Generation of Progress","first-page":"1597","article-title":"Multiple drug abuse patterns and medical consequences","author":"Kreek","year":"1987"},{"key":"10.1016\/j.ejphar.2007.05.007_bib15","doi-asserted-by":"crossref","first-page":"6686","DOI":"10.1523\/JNEUROSCI.1706-04.2004","article-title":"cAMP response element-binding protein is required for stress but not cocaine-induced reinstatement","volume":"24","author":"Kreibich","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2007.05.007_bib16","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0166-2236(91)90141-G","article-title":"The dopamine hypothesis of the reinforcing properties of cocaine","volume":"14","author":"Kuhar","year":"1991","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejphar.2007.05.007_bib17","first-page":"17","article-title":"Watching peptide drugs grow up","volume":"83","author":"Marx","year":"2005","journal-title":"Chem. Eng. News."},{"key":"10.1016\/j.ejphar.2007.05.007_bib18","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0022-3565(24)38137-6","article-title":"Nitrocinnamoyl and chlorocinnamoyl derivatives of dihydrocodeinone: in vivo and in vitro characterization of mu-selective agonist and antagonist activity","volume":"289","author":"McLaughlin","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.05.007_bib19","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.1523\/JNEUROSCI.23-13-05674.2003","article-title":"Kappa-opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses","volume":"23","author":"McLaughlin","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2007.05.007_bib20","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/sj.npp.1300872","article-title":"Prior activation of kappa-opioid receptors by U50,488 mimics repeated forced swim stress to potentiate cocaine-conditioned place preference conditioning","volume":"31","author":"McLaughlin","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2007.05.007_bib21","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1749-6632.2000.tb06678.x","article-title":"Interactions between kappa-opioid agonists and cocaine","volume":"909","author":"Mello","year":"2000","journal-title":"Preclinical studies. Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.ejphar.2007.05.007_bib22","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s00213-004-1878-7","article-title":"Effects of the kappa-opioid agonist U50,488 and the kappa-opioid antagonist nor-binaltorphimine on choice between cocaine and food in rhesus monkeys","volume":"176","author":"Negus","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2007.05.007_bib23","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0006-8993(90)90431-A","article-title":"Stress- and pharmacologically induced behavioral sensitization increases vulnerability to acquisition of amphetamine self-administration","volume":"514","author":"Piazza","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2007.05.007_bib24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0165-0173(00)00024-2","article-title":"Stress-induced relapse to heroin and cocaine seeking in rats: a review","volume":"33","author":"Shaham","year":"2000","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.ejphar.2007.05.007_bib25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0091-3057(00)00185-4","article-title":"Simultaneous monitoring of conditioned place preference and locomotor sensitization following repeated administration of cocaine and amphetamine","volume":"66","author":"Shimosato","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2007.05.007_bib26","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/j.1471-4159.2004.02589.x","article-title":"Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects","volume":"90","author":"Shirayama","year":"2004","journal-title":"J Neurochem."},{"key":"10.1016\/j.ejphar.2007.05.007_bib27","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1073\/pnas.89.6.2046","article-title":"Opposing tonically active endogeous opioid systems modulate the mesolimbic dopaminergic pathway","volume":"89","author":"Spanagel","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejphar.2007.05.007_bib28","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0166-4328(02)00102-X","article-title":"Unconditioned and conditioned factors contribute to the 'reinstatement\u2019 of cocaine place-conditioning following extinction in C57BL\/6J mice","volume":"136","author":"Szumlinski","year":"2002","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2007.05.007_bib29","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1254\/jjp.53.487","article-title":"Further evidence for the implication of a kappa-opioid receptor mechanism in the production of psychological stress-induced analgesia","volume":"53","author":"Takahashi","year":"1990","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.05.007_bib30","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1523\/JNEUROSCI.0685-05.2005","article-title":"Cocaine-induced reinstatement requires endogenous stimulation of mu-opioid receptors in the ventral pallidum","volume":"25","author":"Tang","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2007.05.007_bib31","doi-asserted-by":"crossref","first-page":"9333","DOI":"10.1523\/JNEUROSCI.20-24-09333.2000","article-title":"Kappa-opioid receptor activation modifies dopamine uptake in the nucleus accumbens and opposes the effects of cocaine","volume":"20","author":"Thompson","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2007.05.007_bib32","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0196-9781(87)90046-5","article-title":"The degradation of dynorphin A in brain tissue in vivo and in vitro","volume":"8","author":"Young","year":"1987","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2007.05.007_bib33","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0022-3565(24)36864-8","article-title":"Dynorphin A (1-8) analog, E-2078, crosses the blood\u2013brain barrier in rhesus monkeys","volume":"282","author":"Yu","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.05.007_bib34","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0091-3057(02)00859-6","article-title":"Conditioned place preference after single doses or \u201cbinge\u201d cocaine in C57BL\/6JJ and 129\/J mice","volume":"73","author":"Zhang","year":"2002","journal-title":"Pharmacol. Biochem. Behav."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299907005481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299907005481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T03:59:03Z","timestamp":1762142343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299907005481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":36,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S0014299907005481"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2007.05.007","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reinstatement of cocaine place-conditioning prevented by the peptide kappa-opioid receptor antagonist arodyn","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2007.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}